Immunohistochemical and clinicopathologic features of estrogen receptor-negative, progesterone receptor-positive, HER-2 negative breast carcinomas.
Rosana Pellin De NardiJuliana Araújo CastanhoGabriela RemonattoJorge Villanova BiazúsAndrea Pires DaminPublished in: Revista da Associacao Medica Brasileira (1992) (2021)
Estrogen receptor -/progesterone receptor +/tumors exhibit aggressive behavior, similar to triple-negative tumors. An appropriate categorization of these tumors should be made to improve their therapeutic management.